Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir plus standard of care in hospitalized adults with COVID-19
IRCT20200422047168N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tenofovir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Length of hospital admission, Length of ICU admission and 6 more. Started Apr 2020; status: completed.
02
Drugs
tenofovir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200422047168N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200422047168N1.